News
News
- Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against Lordstown Motors Corp. (RIDE) and May 17 Deadline
03/23/2021 / 15:08 - GlobeNewswire - SBA Celebrates Women’s History Month with Live Online Panel
03/22/2021 / 21:25 - GlobeNewswire - Earth Hour 2021: WWF Hosts a Nationwide Meditation for the Planet
03/22/2021 / 19:40 - GlobeNewswire - Rezolute Presents Data on RZ358 in Post-Gastric Bypass Hypoglycemia at ENDO 2021
03/22/2021 / 13:00 - GlobeNewswire - BioCryst’s Oral Factor D Inhibitor, BCX9930, Advancing to Pivotal Trials in PNH Following Successful Proof of Concept Trial
03/22/2021 / 13:00 - GlobeNewswire - Strongbridge Biopharma plc Presents Detailed Results from Pivotal Phase 3 LOGICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome at the 2021 Annual Meeting of the Endocrine Society (ENDO)
03/20/2021 / 16:00 - GlobeNewswire - Saxena White P.A. Files Securities Fraud Class Action Against Lordstown Motors Corporation
03/19/2021 / 20:36 - GlobeNewswire - Apellis and Sobi: The New England Journal of Medicine Publishes Phase 3 PEGASUS Study Results Comparing Pegcetacoplan to Eculizumab for PNH
03/17/2021 / 22:48 - GlobeNewswire - NEXLETOL® (bempedoic acid) Tablet, ezetimibe and atorvastatin combination lowered bad cholesterol by 60.5% vs. placebo in Phase 2 study
03/17/2021 / 21:05 - GlobeNewswire - VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce Stroke in At-Risk Patients in Analyses of Landmark REDUCE-IT® Study Presented at International Stroke Conference 2021
03/17/2021 / 16:30 - GlobeNewswire
Real-time